BIO announced election of GlycoMimetics President and CEO Rachel King as Board of Directors Chair for 2013–2014 term and Allergan Chairman, President, and CEO David Pyott as Board Secretary. Also, BIO announced re-election of Fenway Pharmaceuticals Chairman and CEO Mark Skaletsky as Board Treasurer as well as election of 19 Directors to serve on BIO's Board Executive Committee. Furthermore, BIO welcomed election of 8 new members to its Board of Directors.
This story is related to the following:Trade Associations